HyperRAB® (rabies immune globulin [human]) – New formulation
February 6, 2018 - Grifols announced the FDA approval of HyperRAB (rabies immune globulin [human]) 300 IU/mL and 1500 IU/5 mL for postexposure prophylaxis, along with rabies vaccine, for all persons suspected of exposure to rabies, except persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer, who should receive only vaccine.
Top